Highlights • Breast cancer patients undergoing systemic treatment have fairly high prevalence of symptomatic dry eye. • Around 40% of them experienced from moderate to severe degree of dry eye. • The severity of symptomatic dry eye in exposure group showed cycle-dependency.
All Keywords
【저자키워드】 Breast cancer, Chemotherapy, targeted therapy, questionnaire, Dry eye, OSDI, NFBSI-16, PRO measures,
【저자키워드】 Breast cancer, Chemotherapy, targeted therapy, questionnaire, Dry eye, OSDI, NFBSI-16, PRO measures,